However, the general rates of target HbA1c level <7.5% and CGM-associated target were unsatisfactory in Chinese T1DM patients who underwent both treatment regimens, indicating the necessity of strengthening publicity and educational programs to improve the management of T1DM patients undergoing intensive insulin therapy. The gene discussed is INS; the disease is type 1 diabetes mellitus.